Showing results (371-380 of 408) with videos related to
Sort By:
Pageof 41
Journal of Neural Transmission (Vienna, Austria : 1996)|March 2, 2026
Tremor in multiple system atrophy: a systematic literature reviewMaria Schneller, Frank Jagusch, Bianca Calio, et al.Investigational New Drugs|March 18, 2017
A randomized, open-label, multicenter, phase II study evaluating the efficacy and safety of BTH1677 (1,3-1,6 beta glucan; Imprime PGG) in combination with cetuximab and chemotherapy in patients with advanced non-small cell lung cancerM Thomas, P Sadjadian, J Kollmeier, et al.Frontiers in Psychology|June 24, 2026
Proximity measurements for objective assessments of crew cohesion in an antarctic space analog environmentMathias Basner, Ka'alana Rennie, Tyler M Moore, et al.Actas Dermo-Sifiliograficas|February 24, 2024
Pityriasis Rubra Pilaris: A Multicentric Case Series of 65 Spanish PatientsJ Montero-Menárguez, V Amat Samaranch, L Puig Sanz, et al.La Revue De Medecine Interne|March 26, 2013
[Anticoagulant clinics are they effective in France? Performance evaluation of six anticoagulant clinics concerning the management of vitamin K antagonists]J P Cambus, D Magnin, C Ambid-Lacombe, et al.Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|March 30, 2021
Perceptions of Tobacco Product-Specific COVID-19 Risk and Changes in Tobacco Use Behaviors Among Smokers, E-Cigarette Users, and Dual UsersAugustus M White, Dongmei Li, L Morgan Snell, et al.Hepatology (Baltimore, Md.)|September 25, 2020
Promoterless, Nuclease-Free Genome Editing Confers a Growth Advantage for Corrected Hepatocytes in Mice With Methylmalonic AcidemiaRandy J Chandler, Leah E Venturoni, Jing Liao, et al.Journal of Surgical Oncology|June 8, 2018
Are there limits of robotic partial nephrectomy? TRIFECTA outcomes of open and robotic partial nephrectomy for completely endophytic renal tumorsNina N Harke, Philipp Mandel, Jorn H Witt, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 25, 2009
Treatment of malignant pleural effusion with the trifunctional antibody catumaxomab (Removab) (anti-EpCAM x Anti-CD3): results of a phase 1/2 studyMartin Sebastian, Philipp Kiewe, Wolfgang Schuette, et al.OTO Open|October 17, 2024
Optimizing Corticosteroid Sinonasal Irrigation Outcomes Through 3D Printing: A Randomized Pilot Clinical TrialZachary T Root, Thomas J Lepley, Kanghyun Kim, et al.Pageof 41